STOCK TITAN

Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Penumbra, Inc. (NYSE: PEN) to present at J.P. Morgan 42nd Annual Healthcare Conference on January 8, 2024
Positive
  • None.
Negative
  • None.

ALAMEDA, Calif., Dec. 18, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on Monday, January 8, 2024.

Event:     J.P. Morgan 42nd Annual Healthcare Conference
Date:       Monday, January 8, 2024
Time:      11:15am ET/8:15am PT

A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com.  The webcast will be available on the company's website for at least two weeks following the event.

About Penumbra 
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-jp-morgan-42nd-annual-healthcare-conference-302018382.html

SOURCE Penumbra, Inc.

Penumbra, Inc. (NYSE: PEN) is scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference.

The presentation is scheduled for Monday, January 8, 2024, at 11:15am ET/8:15am PT.

The webcast of the presentation can be accessed on the 'Events and Presentations' section under the 'Investors' tab of the company's website at www.penumbrainc.com.

The webcast will be available on the company's website for at least two weeks following the event.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Alameda

About PEN

penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.